Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
$0.00
$0.05
$1.97
$25.24M-0.0618,253 shs6,100 shs
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
$0.06
-10.8%
$0.07
$0.05
$0.15
$7.51M1.4511,613 shs750 shs
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
$0.00
$0.00
$0.00
$0.01
$2.58M2.43130,066 shs174,312 shs
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
$23,687,640.18
$0.14
$11.65
$21.71M3.219.52 million shsN/A
Teligent, Inc. stock logo
TLGT
Teligent
$0.03
$0.17
$1.60
N/AN/AN/A6,460 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
0.00%0.00%0.00%0.00%0.00%
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
0.00%-4.45%-13.43%+5.45%-35.98%
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
0.00%0.00%+2.63%-15.22%-64.55%
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
0.00%0.00%0.00%0.00%0.00%
Teligent, Inc. stock logo
TLGT
Teligent
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
N/AN/AN/AN/AN/AN/AN/AN/A
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
0.00
N/AN/AN/A
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
0.00
N/AN/AN/A
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
0.00
N/AN/AN/A
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
0.00
N/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
$20K0.00N/AN/A($0.03) per share0.00
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
N/AN/AN/AN/A($0.04) per shareN/A
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
$820K3.14N/AN/A($0.03) per share-0.13
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
$82.08M0.00N/AN/A($0.58) per share0.00
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
-$1.45MN/A0.00N/AN/A-41,453.98%N/A-574.29%N/A
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
-$2.55M-$0.010.00N/AN/AN/A-609.07%9/23/2025 (Estimated)
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
-$9.91M-$0.020.00N/AN/AN/A-56.69%N/A
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
-$124.51M-$1.39N/AN/AN/A-346.61%-1,430.37%-64.04%N/A
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest INSY, AMAR, CPMD, TLGT, and BETRF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/10/2025Q4 2024
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
N/A-$0.01N/A-$0.01N/A$0.48 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
N/AN/AN/AN/AN/A
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
N/AN/AN/AN/AN/A
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
N/AN/AN/AN/AN/A
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
N/AN/AN/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
N/A
0.03
0.07
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
N/A
0.04
0.03
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
N/A
0.05
0.01
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
N/A
0.54
0.50
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
N/A
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
0.01%
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
N/A
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
14.93%
Teligent, Inc. stock logo
TLGT
Teligent
N/A

Insider Ownership

CompanyInsider Ownership
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
34.35%
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
34.77%
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
1.27%
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
65.40%
Teligent, Inc. stock logo
TLGT
Teligent
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amarillo Biosciences, Inc. stock logo
AMAR
Amarillo Biosciences
242.07 millionN/ANot Optionable
BetterLife Pharma Inc. stock logo
BETRF
BetterLife Pharma
7129.46 million84.45 millionNot Optionable
Golden Dragon Holding Co. stock logo
CPMD
Golden Dragon
4660.63 million652.24 millionNot Optionable
INSYS Therapeutics, Inc. stock logo
INSY
INSYS Therapeutics
22674.57 millionN/AOptionable
Teligent, Inc. stock logo
TLGT
Teligent
2,357N/AN/AOptionable

Recent News About These Companies

PAC Profile: Teligent
IDT Corp. Cl B

New MarketBeat Followers Over Time

Media Sentiment Over Time

Amarillo Biosciences stock logo

Amarillo Biosciences OTCMKTS:AMAR

Amarillo Biosciences, Inc., a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases. The Medical division focuses on medical devices and developing technology to treat metabolism related diseases, such as Type 1 and Type 2 diabetes. The Consumer division provides a range of nutraceutical and food supplement products that utilize a liposomal delivery system. It owns four issued patents related to the low-dose oral delivery of interferon; one patent is for a product promoting oral health; and three patents are associated with treatment of metabolic disorders. The company was incorporated in 1984 and is based in Amarillo, Texas.

BetterLife Pharma stock logo

BetterLife Pharma OTCMKTS:BETRF

$0.06 -0.01 (-10.77%)
As of 07/3/2025 12:34 PM Eastern

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Golden Dragon stock logo

Golden Dragon OTCMKTS:CPMD

$0.0039 0.00 (0.00%)
As of 07/3/2025 11:42 AM Eastern

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

INSYS Therapeutics stock logo

INSYS Therapeutics NASDAQ:INSY

Insys Therapeutics, Inc., a specialty pharmaceutical company, focuses on cannabinoids and drug delivery systems that address unmet patient needs. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It also develops Cannabidiol Oral Solution, a synthetic cannabidiol, for the treatment of rare childhood epilepsy syndromes that include west syndrome and childhood absence epilepsy, as well as glioblastoma multiforme, pontine glioma, and pediatric schizophrenia. In addition, the company develops Buprenorphine Sublingual Spray for acute pain; Epinephrine Nasal Spray for allergic reactions, including anaphylaxis; and Naloxone Nasal Spray for opioid antagonist. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.

Teligent stock logo

Teligent NASDAQ:TLGT

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.